Heron Therapeutics Inc
(NASDAQ:HRTX)
$1.3399
0.1249[10.28%]
Last update: 6:57PM (Delayed 15-Minutes)
Get Real Time Here
$1.3399
0[0.00%]
After-Hours
Open1.220Close1.300
Vol / Avg.2.922M / 2.769MMkt Cap201.082M
Day Range1.220 - 1.35952 Wk Range0.500 - 3.410

Heron Therapeutics Stock (NASDAQ:HRTX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Outperform

Highest Price Target1

$24.00

Lowest Price Target1

$4.00

Consensus Price Target1

$12.67

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
30000

Analyst Firms Making Recommendations1

  • Needham
  • Evercore ISI Group
  • SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Heron Therapeutics

Upgrades (0)

Downgrades (0)

Initiations (0)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/15/2023HRTXBuy Now
Heron Therapeutics
$1.34198.53%Needham
Serge Belanger
$5 → $4MaintainsBuyGet Alert
08/15/2023HRTXBuy Now
Heron Therapeutics
$1.34273.16%Needham
Serge Belanger
→ $5ReiteratesBuy → BuyGet Alert
07/25/2023HRTXBuy Now
Heron Therapeutics
$1.34273.16%Needham
Serge Belanger
$6 → $5MaintainsBuyGet Alert
05/12/2023HRTXBuy Now
Heron Therapeutics
$1.34347.79%Needham
Serge Belanger
$7 → $6MaintainsBuyGet Alert
04/21/2023HRTXBuy Now
Heron Therapeutics
$1.34422.43%Needham
Serge Belanger
→ $7Reiterates → BuyGet Alert
03/24/2023HRTXBuy Now
Heron Therapeutics
$1.34646.32%Evercore ISI Group
Shweta Khajuria
$15 → $10MaintainsOutperformGet Alert
03/24/2023HRTXBuy Now
Heron Therapeutics
$1.34422.43%Needham
Serge Belanger
$8 → $7MaintainsBuyGet Alert
11/09/2022HRTXBuy Now
Heron Therapeutics
$1.34497.06%Needham
Serge Belanger
$10 → $8MaintainsBuyGet Alert
06/30/2022HRTXBuy Now
Heron Therapeutics
$1.34646.32%Needham
Serge Belanger
$14 → $10MaintainsBuyGet Alert
05/10/2022HRTXBuy Now
Heron Therapeutics
$1.34944.85%Needham
Serge Belanger
$16 → $14MaintainsBuyGet Alert
12/02/2020HRTXBuy Now
Heron Therapeutics
$1.341691.18%SVB LeerinkMaintainsOutperformGet Alert
Q

What is the target price for Heron Therapeutics (HRTX)?

A

The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by Needham on November 15, 2023. The analyst firm set a price target for $4.00 expecting HRTX to rise to within 12 months (a possible 198.53% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Heron Therapeutics (HRTX)?

A

The latest analyst rating for Heron Therapeutics (NASDAQ: HRTX) was provided by Needham, and Heron Therapeutics maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Heron Therapeutics (HRTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heron Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heron Therapeutics was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.

Q

Is the Analyst Rating Heron Therapeutics (HRTX) correct?

A

While ratings are subjective and will change, the latest Heron Therapeutics (HRTX) rating was a maintained with a price target of $5.00 to $4.00. The current price Heron Therapeutics (HRTX) is trading at is $1.34, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.